Rydex Europe Advantage Fund Class C (RYCEX)

14.69
Net Asset Value
+0.89%
1 Day
+10.29%
Year-to-Date
Overall Morningstar Rating
Trading-leveraged equity
Style or Category
No Load
Sales Expenses
2.47%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks to provide investment results that correlate, before fees and expenses, to the performance of 125% of the fair value of the STOXX Europe 50 ® Index. The fund employs as its investment strategy a program of investing in the common stock of companies that are generally within the capitalization range of the underlying index and derivative instruments. It will invest at least 80% of its net assets, plus any borrowings for investment purposes, in securities of companies in the underlying index and derivatives and other instruments whose performance is expected to correspond to that of the underlying index. The fund is non-diversified.

Performance

1 month+2.10% 3 years+9.73%
3 months+7.77% 5 years+2.49%
1 year-7.39% Since inception-1.33%
Data through --

Peer Comparisonvs. Trading-leveraged equity

 RYCEXCategory
Performance 5-yr return+2.49%+16.48%
Expense ratio2.47%2.05%
Risk 5 year sharpe ratio0.16--
Net assets$11.9M$83.3M
Average market cap$103.8B--
Average P/E19.5--
Portfolio turnover654%654%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyRydex Funds
Fund manager & tenureMichael Byrum / 14 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00

Holdings

Cash60.02%
International stock41.09%
U.S. stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Financial service 21.80%
Energy 20.96%
Telecommunication 16.63%
Healthcare 16.00%
Industrial materials 14.03%
Top 10 Holdings
Portfolio weighting
NVS Novartis2.63%
NSRGY Nestle2.52%
RHHBY Roche2.01%
HSBC HSBC1.70%
BAYRY Bayer1.29%
SNY Sanofi1.25%
TOT Total1.22%
BP BP1.22%
RDSA Royal Dutch Shell1.20%
GSK GlaxoSmithKline1.16%

To view my watchlist

Not a member yet?

Sign up now for a free account